James Moser

Papers

Total Citations

H-Index

About

James Moser is a leading surgical oncologist whose research focuses on improving outcomes for patients with pancreatic cancer, particularly through the integration of advanced radiotherapy and surgical techniques. His most cited work, "Adjuvant Stereotactic Body Radiotherapy for Resected Pancreatic Adenocarcinoma with Close or Positive Margins" (2010, 57 citations), established a critical paradigm for managing high-risk surgical margins. By demonstrating that stereotactic body radiotherapy (SBRT) could effectively sterilize residual microscopic disease after pancreatectomy, Moser helped bridge a gap between aggressive surgery and local tumor control. This contribution has influenced clinical guidelines and spurred further investigation into precision radiotherapy for pancreatic malignancies. Beyond this landmark study, Moser's broader research portfolio explores novel therapeutic combinations, including immunotherapy and targeted agents, to address the notoriously poor prognosis of pancreatic adenocarcinoma. His work is characterized by a translational focus, seeking to convert laboratory insights into tangible survival benefits. With a career dedicated to tackling one of oncology’s most challenging diseases, Moser’s impact is measured not only in citations but in the improved surgical and adjuvant strategies now available to patients.